摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,4-tri-O-benzoyl-6-O-bromoacetyl-α-D-galactopyranosyl bromide | 100776-43-0

中文名称
——
中文别名
——
英文名称
2,3,4-tri-O-benzoyl-6-O-bromoacetyl-α-D-galactopyranosyl bromide
英文别名
[(2R,3S,4S,5R,6R)-4,5-dibenzoyloxy-6-bromo-2-[(2-bromoacetyl)oxymethyl]oxan-3-yl] benzoate
2,3,4-tri-O-benzoyl-6-O-bromoacetyl-α-D-galactopyranosyl bromide化学式
CAS
100776-43-0
化学式
C29H24Br2O9
mdl
——
分子量
676.312
InChiKey
AQVJPQFZBPWMPF-RGFLIBBCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.72
  • 重原子数:
    40.0
  • 可旋转键数:
    9.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    114.43
  • 氢给体数:
    0.0
  • 氢受体数:
    9.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3,4-tri-O-benzoyl-6-O-bromoacetyl-α-D-galactopyranosyl bromide2,4,6-三甲基吡啶silver trifluoromethanesulfonate 、 zinc(II) chloride 作用下, 以 二氯甲烷氯仿 为溶剂, 反应 4.5h, 生成 Methyl O-(2,3,4-tri-O-benzoyl-6-O-bromoacetyl-β-D-galactopyranosyl)-(1->6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside
    参考文献:
    名称:
    Binding studies on internal immunodeterminants: synthesis of β-(1 → 6)-linked oligosaccharide methyl glycosides having one to four internal d-galactopyranosyl residues flanked by gentiobiose residues
    摘要:
    The oligosaccharide glycosides beta-D-Glc p-(1 --> 6)-beta-D-Glc p-(1 --> 6)-[beta-D-Gal p-(1 --> 6)]n-beta-D-Glc p-(1 --> 6)-beta-D-Glc p-1 --> OMe (n = 1-4) were prepared by a convergent block synthesis. Haloacetyl, tert-butyldiphenylsilyl, and dimethylthexylsilyl groups were used as temporary protective groups for the preparation of the intermediate glycosyl donors and acceptors. The deoxygenated trisaccharide glyco-sides beta-D-Glc p-(1 --> 6)-beta-D-Gal p-(1 --> 6)-4-deoxy-beta-D-xylo-Hex p-1 --> OMe and beta-D-Glc p-(1 --> 6)-4-deoxy-beta-D-xylo-Hex p-(1 --> 6)-beta-D-Gal p-1 --> OMe were also synthesized. The binding of each glycoside to the monoclonal antigalactan antibody IgA 1539 was studied and the results support the previous finding that J539 can bind to internal antigenic epitopes. The data are consistent with the interpretation that subsite C of that antibody binds glucose with a K(a) of approximately 6 (cf. 10.9 for galactose).
    DOI:
    10.1016/s0008-6215(00)90575-5
  • 作为产物:
    描述:
    1,2,3,4-tetra-O-benzoyl-β-D-galactopyranose 在 2,6-二甲基吡啶氢溴酸 作用下, 以 二氯甲烷溶剂黄146 为溶剂, 反应 0.84h, 生成 2,3,4-tri-O-benzoyl-6-O-bromoacetyl-α-D-galactopyranosyl bromide
    参考文献:
    名称:
    甲基O-(3-deoxy-3-fluoro-β-d-galactopyranosyl)-(1→6)-O-β-d-galactopyranosyl-(1→6)-3-deoxy-3-fluoro-β的合成-d-吡喃半乳糖苷和相关的nmr研究
    摘要:
    依次对甲基3-脱氧-3-氟-β-D-吡喃半乳糖苷进行三苯甲基化,苯甲酰化和去三苯甲基化,得到结晶的甲基2,4-二-O-苯甲酰基-3-脱氧-3-氟-β-D-吡喃半乳糖苷(9 ),它被用作目标寡糖合成中的初始亲核试剂(16)。用2,3,4-三-O-苯甲酰基-6-O-溴乙酰基-α-D-吡喃半乳糖基溴化物处理9,得到相应的二糖衍生物13,其在O-6'处具有可选择性除去的保护基。13的脱溴乙酰化得到二糖亲核体14,当用2,4,6-三-O-苯甲酰基-3-脱氧-3-氟-α-D-吡喃半乳糖基溴化物处理时,得到完全保护的三糖15。15的脱苯甲酰化得到标题糖苷16。在共聚可力丁存在下,在碱缺陷条件下,用三氟甲烷磺酸银作为促进剂进行缩合反应,得到所需β(反式)产物的优异产率。通过使用各种一维和二维nmr技术,对1H和13C-nmr光谱进行了分析,并确定了JCF和JHF耦合常数。
    DOI:
    10.1016/0008-6215(85)85130-2
点击查看最新优质反应信息

文献信息

  • Synthesis of p-nitrophenyl β-glycosides of (1→6)-β-d-galactopyranosyl-oligosaccharides
    作者:Göran Ekborg、Branka Vranešić、Apurba K. Bhattacharjee、Pavol Kováč、Cornelis P.J. Glaudemans
    DOI:10.1016/0008-6215(85)85023-0
    日期:1985.10
    Sequential tritylation, benzoylation, and detritylation of p-nitrophenyl beta-D-galactopyranoside gave p-nitrophenyl 2,3,4-tri-O-benzoyl-beta-D-galactopyranoside (2). Reaction of 2 with 2,3,4,6-tetra-O-benzoyl-alpha-D-galactopyranosyl bromide gave p-nitrophenyl O-(2,3,4,6-tetra-O-benzoyl-beta-D-galactopyranosyl)-(1----6) -2,3,4-tri-O-benzoyl-beta-D-galactopyranoside (4) in 94% yield. Deprotection with
    对硝基苯基β-D-吡喃半乳糖苷的顺序三苯甲基化,苯甲酰化和去三苯甲基化得到对硝基苯基2,3,4-三-O-苯甲酰基-β-D-吡喃半乳糖苷(2)。2与2,3,4,6-四-O-苯甲酰基-α-D-吡喃半乳糖基溴的反应得到对硝基苯基O-(2,3,4,6-四-O-苯甲酰基-β-D-吡喃半乳糖基)-(1 ---- 6)-2,3,4-三-O-苯甲酰基-β-D-吡喃半乳糖苷(4),产率94%。然后用甲醇钠脱保护,得到结晶的对硝基苯基O-(β-D-吡喃半乳糖基)-(1-6)-β-D-吡喃半乳糖苷(5)。2与2,3,4-三-O-苯甲酰基-6-O-溴乙酰基-α-D-吡喃半乳糖基溴化物(3)的缩合反应很容易得到保护的二糖对硝基苯基O-(2,3,4-三- O-苯甲酰基-6-O-溴乙酰基-β-D-吡喃半乳糖基)-(1 ---- 6)-2,3,4-三-O-苯甲酰基-β-D-吡喃半乳糖苷(6),可从其中选择性除去溴乙酰基。
  • Synthetic mucin fragments: synthesis of O-sulfo and O-methyl derivatives of allyl O-(β-d-galactopyranosyl)-(1 → 3)-2-acetamido-2-deoxy-α-d-galactopyranoside as potential compounds for sulfotransferases
    作者:Rakesh K. Jain、Conrad F. Piskorz、Khushi L. Matta
    DOI:10.1016/0008-6215(95)00162-m
    日期:1995.10
    galactopyranoside (5), allyl O-(6-O-sulfo-beta-D-galactopyranosyl sodium salt)-(1-->3)-2-acetamido-2-deoxy-6- O-methyl-alpha-D-galactopyranoside (10), allyl O-(beta-D-galactopyranosyl)-(1-->3)-2-acetamido-2-deoxy-6-O-sulfo-alpha- D- galactopyranoside sodium salt (13), allyl O-(6-O-sulfo-beta-D-galactopyranosyl sodium salt)-(1-->3)-2-acetamido-2-deoxy- alpha-D-galactopyranoside (17) and allyl O-(3-O-sulfo-beta-D-galactopyranosyl
    将烯丙基2-乙酰氨基-4,6-O-(4-甲氧基亚苄基)-2-脱氧-α-D-半乳清鸦片核苷(1)与2,3,4,6-四-O-乙酰基-α缩合在氰化汞的存在下,-D-吡喃半乳糖基溴化物(2)或2,3,4-三-O-苯甲酰基-6-O-溴乙酰基-α-D-吡喃半乳糖基溴化物(14)。在所需位置用甲基,磺基或两者选择性取代,然后除去保护基,得到烯丙基O-(β-D-吡喃半乳糖基)-(1→3)-2-乙酰氨基-2-脱氧-6- O-甲基-α-D-吡喃半乳糖苷(5),烯丙基O-(6-O-磺基-β-D-吡喃半乳糖基钠盐)-(1-> 3)-2-乙酰氨基-2-脱氧-6- O-甲基-α-D-吡喃半乳糖苷(10),烯丙基O-(β-D-吡喃半乳糖基)-(1-> 3)-2-乙酰氨基-2-脱氧-6-O-磺基-α-D-吡喃半乳糖苷钠盐(13),烯丙基O-(6-O-磺基-β-D-吡喃半乳糖苷钠盐)-(1-> 3)-2-乙酰氨基-2-脱氧
  • Binding studies on internal immunodeterminants: synthesis of β-(1 → 6)-linked oligosaccharide methyl glycosides having one to four internal d-galactopyranosyl residues flanked by gentiobiose residues
    作者:Thomas Ziegler、Heinz Sutoris、Cornelis P.J. Glaudemans
    DOI:10.1016/s0008-6215(00)90575-5
    日期:1992.5
    The oligosaccharide glycosides beta-D-Glc p-(1 --> 6)-beta-D-Glc p-(1 --> 6)-[beta-D-Gal p-(1 --> 6)]n-beta-D-Glc p-(1 --> 6)-beta-D-Glc p-1 --> OMe (n = 1-4) were prepared by a convergent block synthesis. Haloacetyl, tert-butyldiphenylsilyl, and dimethylthexylsilyl groups were used as temporary protective groups for the preparation of the intermediate glycosyl donors and acceptors. The deoxygenated trisaccharide glyco-sides beta-D-Glc p-(1 --> 6)-beta-D-Gal p-(1 --> 6)-4-deoxy-beta-D-xylo-Hex p-1 --> OMe and beta-D-Glc p-(1 --> 6)-4-deoxy-beta-D-xylo-Hex p-(1 --> 6)-beta-D-Gal p-1 --> OMe were also synthesized. The binding of each glycoside to the monoclonal antigalactan antibody IgA 1539 was studied and the results support the previous finding that J539 can bind to internal antigenic epitopes. The data are consistent with the interpretation that subsite C of that antibody binds glucose with a K(a) of approximately 6 (cf. 10.9 for galactose).
  • Synthesis of methyl O-(3-deoxy-3-fluoro-β-d-galactopyranosyl)-(1→6)-O-β-d-galactopyranosyl-(1→6)-3-deoxy-3-fluoro -β-d-galactopyranoside and related n.m.r. studies
    作者:Pavol Kováč、Cornelis P.J. Glaudemans、Wie Guo、Tuck C. Wong
    DOI:10.1016/0008-6215(85)85130-2
    日期:1985.7
    Sequential tritylation, benzoylation, and detritylation of methyl 3-deoxy-3-fluoro-beta-D-galactopyranoside gave crystalline methyl 2,4-di-O-benzoyl-3-deoxy-3-fluoro-beta-D-galactopyranoside (9), which was used as the initial nucleophile in the synthesis of the target oligosaccharide (16). Treatment of 9 with 2,3,4-tri-O-benzoyl-6-O-bromoacetyl-alpha-D-galactopyranosyl bromide gave the corresponding
    依次对甲基3-脱氧-3-氟-β-D-吡喃半乳糖苷进行三苯甲基化,苯甲酰化和去三苯甲基化,得到结晶的甲基2,4-二-O-苯甲酰基-3-脱氧-3-氟-β-D-吡喃半乳糖苷(9 ),它被用作目标寡糖合成中的初始亲核试剂(16)。用2,3,4-三-O-苯甲酰基-6-O-溴乙酰基-α-D-吡喃半乳糖基溴化物处理9,得到相应的二糖衍生物13,其在O-6'处具有可选择性除去的保护基。13的脱溴乙酰化得到二糖亲核体14,当用2,4,6-三-O-苯甲酰基-3-脱氧-3-氟-α-D-吡喃半乳糖基溴化物处理时,得到完全保护的三糖15。15的脱苯甲酰化得到标题糖苷16。在共聚可力丁存在下,在碱缺陷条件下,用三氟甲烷磺酸银作为促进剂进行缩合反应,得到所需β(反式)产物的优异产率。通过使用各种一维和二维nmr技术,对1H和13C-nmr光谱进行了分析,并确定了JCF和JHF耦合常数。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐